Eli Lilly CEO publicly disputes Anthropic chief Dario Amodei's claims about medical AI
The chief executive of Eli Lilly has reportedly pushed back against assertions made by Dario Amodei, head of AI company Anthropic, regarding medical advances. The criticism appears in a Substack post by researcher Gary Marcus, which was shared on Hacker News. The source material provided is limited to a link and basic engagement metadata, so the specific claims and rebuttal details could not be independently verified. The post characterizes Amodei's statements as ludicrous, though that framing reflects the commentary rather than a confirmed fact. Further reporting would be needed to establish the exact substance of the disagreement.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in